PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'School of Chemistry & Molecular Biosciences, The University of Queensland, Brisbane, Queensland, 4072, Australia.\', \'Australian Infectious Diseases Research Centre, The University of Queensland, Brisbane, Queensland, 4072, Australia.\', \'School of Pharmacy and Medical Science, Griffith University Gold Coast Campus, Queensland, Australia.\', \'The Rosalind Franklin Institute Harwell Campus, Didcot, OX11 0FA, UK.\', \'Department of Chemistry, University of York Heslington, York, YO10 5DD, UK.\', \'Centre for Genomics and Personalised Health School of Chemistry and Physics, Queensland University of Technology, 2 George St, Brisbane, QLD, 4000, Australia.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1002/chem.202104222
?:doi
?:hasPublicationType
?:journal
  • Chemistry (Weinheim an der Bergstrasse, Germany)
is ?:pmid of
?:pmid
?:pmid
  • 34981584
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Structural Insights into Pixatimod (PG545) Inhibition of Heparanase, a Key Enzyme in Cancer and Viral Infections.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all